Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alejandra Martinez-Trillo"'
Autor:
Maria del Carmen García Garay, Concepción Ruiz, Alejandra Martinez-Trillo, Andrés Romo Collado, Ana Iglesias Pérez, María José Sánchez, Isabel Mata, Jose Luis Lopez Lorenzo, Guiomar Bautista, Juan Luis Steegmann, Beatriz Cuevas, Ana Sebrango, Alberto Alvarez, Guillermo Deben, Fernando Ortega, Esperanza Romero, Concepción Boqué, Maria Luisa Martin Mateos, Sandra Valencia, Angeles Fernandez, Angeles Portero, Pilar Giraldo, Sabela Bobillo, Natalia de las Heras, José Tallón, José María Guinea, Valentín García-Gutiérrez, Begoña Maestro
Publikováno v:
Blood. 124:5523-5523
Second-generation TKIs have demonstrated efficacy and an acceptable tolerability in patients (pts) with chronic myeloid leukemia (CML); however, new data from so called “off target” side effects have been published. For example, serious concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e4792cc83943dc85b8376385f37196
https://doi.org/10.1182/blood.v124.21.5523.5523
https://doi.org/10.1182/blood.v124.21.5523.5523
Autor:
Neus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, Mónica Lopez-Guerra, Laia Rosich, Ferran Nadeu, Juan G. Valero, Marta Aymerich, Laura Magnano, Maria Rozman, Estella Matutes, Julio Delgado, Tycho Baumann, Eva Gine, Marcos González, Miguel Alcoceba, M. José Terol, Blanca Navarro, Enrique Colado, Angel R. Payer, Xose S. Puente, Carlos López-Otín, Armando Lopez-Guillermo, Elias Campo, Dolors Colomer, Neus Villamor
Publikováno v:
Haematologica, Vol 104, Iss 3 (2019)
Mutations in genes of the RAS-BRAF-MAPK-ERK pathway have not been fully explored in patients with chronic lymphocytic leukemia. We, therefore, analyzed the clinical and biological characteristics of chronic lymphocytic leukemia patients with mutation
Externí odkaz:
https://doaj.org/article/402de343009a456fb550859f79eb4bb3
Autor:
Alba Navarro, Guillem Clot, Alejandra Martínez-Trillos, Magda Pinyol, Pedro Jares, Blanca González-Farré, Daniel Martínez, Nicola Trim, Verónica Fernández, Neus Villamor, Dolors Colomer, Dolors Costa, Itziar Salaverria, David Martín-Garcia, Wendy Erber, Cristina López, Sandrine Jayne, Reiner Siebert, Martin J. S. Dyer, Adrian Wiestner, Wyndham H. Wilson, Marta Aymerich, Armando López-Guillermo, Àlex Sánchez, Elías Campo, Estella Matutes, Sílvia Beà
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
Externí odkaz:
https://doaj.org/article/d0b8679566504653b9d5d68cbc5b1817
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julio Delgado, Itziar Salaverria, Tycho Baumann, Alejandra Martínez-Trillos, Eriong Lee, Laura Jiménez, Alba Navarro, Cristina Royo, Rodrigo Santacruz, Cristina López, Angel R. Payer, Enrique Colado, Marcos González, Lluís Armengol, Dolors Colomer, Magda Pinyol, Neus Villamor, Marta Aymerich, Ana Carrió, Dolors Costa, Guillem Clot, Eva Giné, Armando López-Guillermo, Elías Campo, Sílvia Beà
Publikováno v:
Haematologica, Vol 99, Iss 11 (2014)
Externí odkaz:
https://doaj.org/article/034115b394c64af29bfde96f16e23115
Autor:
Tycho Baumann, Julio Delgado, Rodrigo Santacruz, Alejandra Martínez-Trillos, Cristina Royo, Alba Navarro, Magda Pinyol, María Rozman, Arturo Pereira, Neus Villamor, Marta Aymerich, Cristina López, Anna Carrió, Emili Montserrat
Publikováno v:
Haematologica, Vol 99, Iss 10 (2014)
We investigated the clinico-biological features, outcomes, and prognosis of 949 patients with chronic lymphocytic leukemia according to age. No biological differences (cytogenetics by fluorescent in situ hybridization, IGHV, ZAP-70, CD38, NOTCH1, SF3
Externí odkaz:
https://doaj.org/article/cebd66195aa846afb478442b019e2ccf
Autor:
Rodrigo Santacruz, Neus Villamor, Marta Aymerich, Alejandra Martínez-Trillos, Cristina López, Alba Navarro, María Rozman, Sílvia Beà, Cristina Royo, Maite Cazorla, Dolors Colomer, Eva Giné, Magda Pinyol, Xose S. Puente, Carlos López-Otín, Elías Campo, Armando López-Guillermo, Julio Delgado
Publikováno v:
Haematologica, Vol 99, Iss 5 (2014)
A proportion of patients with chronic lymphocytic leukemia achieve a minimal residual disease negative status after therapy. We retrospectively evaluated the impact of minimal residual disease on the outcome of 255 consecutive patients receiving any
Externí odkaz:
https://doaj.org/article/b2a4919bf4654c6094873c23b41c2729